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Abstract
Introduction: The development of metabolic syndrome (MetS) is influenced by environmental factors such as smoking and
alcohol consumption. We determined the combined effects of smoking and alcohol on MetS and its individual components.
Methods: 64,046 participants aged 18–80 years from the LifeLines Cohort study were categorized into three body mass
index (BMI) classes (BMI,25, normal weight; BMI 25–30, overweight; BMI$30 kg/m2, obese). MetS was defined according to
the revised criteria of the National Cholesterol Education Program’s Adult Treatment Panel III (NCEP ATP III). Within each BMI
class and smoking subgroup (non-smoker, former smoker, ,20 and $20 g tobacco/day), the cross-sectional association
between alcohol and individual MetS components was tested using regression analysis.
Results: Prevalence of MetS varied greatly between the different smoking-alcohol subgroups (1.7–71.1%). HDL cholesterol
levels in all alcohol drinkers were higher than in non-drinkers (0.02 to 0.29 mmol/L, P values,0.001). HDL cholesterol levels
were lower when they were also a former or current smoker (,20 and $20 g tobacco/day). Consumption of #1 drink/day
indicated a trend towards lower triglyceride levels (non-significant). Concurrent use alcohol (.1 drink/day) and tobacco
showed higher triglycerides levels. Up to 2 drinks/day was associated with a smaller waist circumference in overweight and
obese individuals. Consumption of.2 drinks/day increased blood pressure, with the strongest associations found for heavy
smokers. The overall metabolic profile of wine drinkers was better than that of non-drinkers or drinkers of beer or spirits/
mixed drinks.
Conclusion: Light alcohol consumption may moderate the negative associations of smoking with MetS. Our results suggest
that the lifestyle advice that emphasizes smoking cessation and the restriction of alcohol consumption to a maximum of 1
drink/day, is a good approach to reduce the prevalence of MetS.
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Introduction
The metabolic syndrome (MetS) is present in approximately
one-fourth of the adult European population [1] and mainly the
result of overweight and obesity [2]. The syndrome is made up of a
number of different components, namely high plasma glucose,
high triglycerides, low high-density lipoprotein cholesterol, high
blood pressure and enlarged waist circumference, which are all
associated with excess adiposity. As a result of these metabolic
abnormalities, there are four main health risks attributable to
MetS, namely type 2 diabetes mellitus, cardiovascular disease,
some types of cancer and all-cause mortality [2,3]. The clinical
management of MetS may depend on lifestyle changes and
minimizing the components that characterize MetS. However,
interventions aimed at weight loss and weight management
showed only to be effective in the short term [4,5]. By contrast,
clinical and public health interventions were effective in reducing
blood pressure and cholesterol in whole populations [6,7].
Controlling the metabolic components might help to tackle the
adverse effects of MetS resulting from the obesity epidemic. It is
therefore important to investigate how lifestyle factors influence
the components of MetS within people with a different body mass
index (BMI), as a measure for obesity.
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In this paper we focus on the two lifestyle factors smoking and
alcohol consumption. Substantial evidence from epidemiological
and clinical studies has shown that tobacco and alcohol are often
used together, with smokers being more likely to drink than non-
smokers and drinkers more likely to smoke than non-drinkers [8].
Although a dose-dependent association between tobacco use and
the risk of developing MetS has been found [9,10], the relationship
between alcohol consumption and MetS is not consistent [11–18].
In addition to this, it is not well established how MetS is affected
by the combination of these two lifestyle factors. The fact that
tobacco and alcohol use do not affect the individual MetS
components in a similar way makes the association complex. For
instance, alcohol consumption is found to be positively correlated
with high-density lipoprotein cholesterol (HDL-C) in a dose-
dependent fashion, while smoking has the opposite effect [19].
Similarly, alcohol and smoking have opposite effects on insulin
sensitivity, with alcohol having favorable effects [20,21]. A further
apparent contrast between these two factors is their effect on blood
pressure. While alcohol consumption of three or more drinks per
day increases blood pressure [22], the relationship between
smoking and blood pressure is less clear or even non-existent
[9,23]. On the other hand, both smoking and alcohol consumption
seem to have a positive association with triglyceride levels [9,24]
and abdominal obesity [9,25,26].
In an earlier paper, we reported on the relationship between
smoking and MetS [9]. In the present study, we carefully assessed
the combined effects of smoking and alcohol consumption on
MetS and its individual components among normal weight,
overweight and obese subjects from LifeLines, a very large
population-based cohort study in the Netherlands (64,046
individuals). We also assessed whether the prevalence of MetS
and its individual components was associated with the type of
alcoholic beverage consumed. If we can identify how smoking and
alcohol together influence MetS, we are better able to give tailored
lifestyle advice to those at higher risk for developing MetS. To our
knowledge, these lifestyle factors have not been explored directly
or so extensively by other studies.
Materials and Methods
Study Design and Subjects
The LifeLines Cohort Study is a multidisciplinary prospective
population-based cohort study with a unique three-generation
design that examines the health and health-related behaviours of
participants living in the north-eastern region of the Netherlands.
More information about the LifeLines Cohort Study can be found
elsewhere [27]. Similar to our previous paper [9] we included
subjects of Western European origin (according to self-reported
information in the questionnaire). They were aged between 18 and
80 years and participated in the study between December 2006
and December 2012. We excluded individuals who had missing
data on BMI (n= 15), or on the variables needed to define MetS
(n = 480), or whose questionnaires were incomplete with regard to
smoking (n= 918) or alcohol consumption (n= 2,590). The current
dataset comprised 64,046 individuals available for analyses. Before
participating in the study, all participants provided written
informed consent. The study protocol was approved conforming
to the Declaration of Helsinki by the medical ethical review
committee of the University Medical Center Groningen.
Outcome Measures
Clinical measures. A fixed staff of well-trained technicians,
who had a long experience in the clinical practice, used a
standardized protocol to obtain blood pressure and anthropomet-
ric measurements: height, weight, and waist circumference.
Systolic and diastolic blood pressures were measured 10 times
during a period of 10 minutes, using an automated Dinamap
Monitor (GE Healthcare, Freiburg, Germany). The size of the cuff
was chosen according to the arm circumference. The average of
the final three readings was used for each blood pressure
parameter. Anthropometric measurements were measured with-
out shoes. Body weight was measured to the nearest 0.1 kg. Height
and waist circumference were measured to the nearest 0.5 cm.
Height was measured with a stadiometer placing their heels
against the rod and the head in Frankfort Plane position. Waist
circumference was measured in standing position with a tape
measure all around the body, at the level midway between the
lower rib margin and the iliac crest.
Biochemical measures. Blood was collected in the fasting
state, between 8.00 and 10.00 a.m., and transported to the
LifeLines central laboratory facility at room temperature or at
4uC, depending on the sample requirements. On the day of
collection, serum levels of total and HDL cholesterol were
measured using an enzymatic colorimetric method, triglycerides
using a colorimetric UV method, and LDL-C using an enzymatic
method, all on a Roche Modular P chemistry analyzer (Roche,
Basel, Switzerland). Fasting blood glucose was measured using a
hexokinase method.
Definition of the Body Mass Index classes (BMI) and
metabolic syndrome. Subjects were classified into three BMI
classes: normal weight (BMI,25.0 kg/m2), overweight (BMI 25.0
to 30.0 kg/m2) or obese (BMI$30.0 kg/m2), calculated as weight
(kg) divided by height squared (m2). Metabolic syndrome was
defined according to the revised criteria of the National
Cholesterol Education Program’s Adult Treatment Panel III
(NCEP ATP III) [28]. The NCEP ATP III stipulates the following
five criteria for MetS: (1) systolic blood pressure$130 mmHg
and/or diastolic blood pressure$85 mmHg and/or use of
antihypertensive medication; (2) fasting blood glucose$
5.6 mmol/L and/or use of blood glucose-lowering medication
and/or diagnosis of type 2 diabetes; (3) HDL cholesterol levels,
1.03 mmol/L in men and,1.30 mmol/L in women and/or use of
lipid-lowering medication; (4) triglyceride levels$1.70 mmol/L
and/or use of triglyceride-lowering medication; and (5) waist
circumference $102 cm in men and$88 cm in women. Individ-
uals were diagnosed as having MetS if at least three of the five
criteria were present. Medication use was self-reported. Diagnosis
of diabetes mellitus was based either on self-report, or on the
finding of a fasting plasma glucose.7.0 mmol/L.
Data on Smoking, Alcohol Consumption and Medication
Use
Information about smoking, alcohol consumption and medica-
tion use was collected from the self-administered questionnaires
(http://www.p3gobservatory.org/catalogue.htm?questionnaireId=
48). Non-smokers were those who had not smoked during the last
month and had never smoked for longer than a year. Subjects were
classified as a former smoker when they reported that they had
smoked during a whole year, had not smoked during the last month
and stopped smoking. Those who had smoked for longer than a
year and had not stopped smoking were classified as current
smoker. Total tobacco use of the current smokers was estimated by
using the following quantities: 1 cigarette= 1 g tobacco, 1
cigarillo = 3 g tobacco and 1 cigar= 5 g tobacco. Moderate
smoking was defined as 20 g/day or less, and heavy as more than
20 g/day [9].
Alcohol intake was based on the response to specific questions
regarding intake frequency and the average number of units
Combined Effects of Smoking and Alcohol on Metabolic Syndrome
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consumed on a drinking day. Individuals who reported not having
consumed alcohol during the past month were considered non-
drinkers. The number of alcoholic drinks per week was
determined by multiplying the number of drinking days per week
by the average number of units consumed on a drinking day. We
then divided the number of alcoholic drinks/week by 7 in order to
arrive at the number of alcoholic drinks per day. Individuals were
classified into four groups according to their daily alcohol intake: 0
drinks/day (non-drinker), #1 drink/day (light drinker), .1 to 2
drinks/day (moderate drinker) and .2 drinks/day (heavy drinker).
In the Netherlands a standard unit contains 9.9 grams of alcohol.
For each type of alcoholic beverage, respondents indicated
whether they consumed it never (0%), sometimes (30%), often
(70%) or always (100%). We only included participants in the beer
group, wine group (which included red wine, white wine, rose´,
sherry, port, vermouth and madeira) or spirits/mixed drinks group
(containing a spirit and a mixer) if that beverage type accounted
for 70% or more of their alcohol consumption. Since very few
participants consumed mainly spirits or mixed drinks, these two
groups were pooled together.
All medications used by participants were classified according to
the Anatomical Therapeutic Chemical (ATC) classification system.
Medication use was then categorized into three groups: non users,
#5 types of medication and .5 types of medication.
Statistical Analysis
All analyses were conducted using IBM SPSS Statistics version
20 (IBM Corporation, Armonk, NY, USA). Continuous data are
expressed as mean 6 standard deviation (SD), and non-normally
distributed data as geometric mean and interquartile range. For
categorical variables, percentages are reported. Differences
between the three BMI classes and four alcohol groups were
tested using ANOVA for continuous data and chi-square test for
categorical data.
Multivariate linear regression models were used to examine the
associations between alcohol use, smoking and the five compo-
nents of MetS, within the three BMI classes. Triglycerides and
fasting blood glucose were log-transformed (natural log). Measured
systolic and diastolic blood pressure were corrected for blood
pressure-lowering medication by adding 10 mmHg and 5 mmHg,
respectively. In Genomic Wide Association Studies this method is
commonly used to approximate the true blood pressure values in
treated subjects for high blood pressure [29–31]. This method is a
better solution than ignoring treatment or excluding treated
subjects [32,33]. Analyses were stratified according to BMI class
and smoking subgroups and adjusted for age (centered at the mean
age of the total population (45y)), sex and the number of
medications used. To assess beverage-specific associations with
MetS and its components, we applied multivariate logistic
regression models with non-drinkers as the reference group. MetS
and the individual components were defined as ‘not meeting the
criteria’ and ‘meeting the criteria’, as defined by the NCEP ATP
III. These models were not stratified for BMI class and smoking
subgroups due to the low number of drinkers who indicated
consuming mainly beer, mainly wine or mainly spirits/mixed
drinks. Models were adjusted for age, sex, BMI class, alcohol
consumption subgroups, smoking subgroups and the number of
medications used. To account for the number of independent tests,
we applied a Bonferroni correction. Given the use of 12
independent tests (three BMI classes x four smoking subgroups),
a P value of#0.004 (0.05/12) was considered significant.
Results
Overweight and obese subjects were slightly older than those
with normal weight (table 1). Participants with a higher BMI had
higher levels of systolic and diastolic blood pressure, serum
triglycerides and blood glucose, and lower levels of HDL-C. The
proportion of former smokers in the overweight and obese groups
was higher than in the normal weight group, whereas the
proportion of current smokers was approximately the same
(normal weight 22.2%, overweight 20.8% and obese 19.4%).
Among obese individuals, 25.8% were non-drinkers, while this
percentage was much lower in overweight (15.0%) and normal
weight (14.8%) individuals. Characteristics of the study popula-
tion, according to alcohol consumption groups is available (Table
S1).
For all three BMI classes, individuals were most frequently
classified as being a non-smoker with an alcohol intake of#1
drink/day (Table 2). The prevalence of MetS is given for each of
the smoking and alcohol subgroups (Table S2 and figure 1). The
percentages of subjects with MetS ranged widely across the
different subgroups and BMI classes (normal weight: 1.7%–8.2%,
overweight: 13.0%–32.1%, obese: 39.8%–71.1%).
There was a dose-dependent increase in HDL-C levels with
increasing levels of alcohol consumption, in all three BMI classes
(P values #0.001) (Figure 2). When we looked at smoking status,
we found that smokers had lower HDL-C levels than non-smokers,
which decreased with the amount of tobacco used.
In all BMI classes, alcohol consumption of .1 drink/day
showed a positive association with triglyceride levels (Figure S1a).
Triglyceride levels also increased within each smoking subgroup. It
should however be noted that only a few results reached statistical
significance.
Although alcohol consumption does appear to increase fasting
glucose levels, these differences were rather small and not
statistically significant (Figure S1b). The relation between alcohol
consumption and systolic blood pressure (SBP) and diastolic blood
pressure (DBP) showed a J-shaped curve (Figure S1c and S1d).
With higher blood pressure levels found among non-drinkers and
moderate to heavy drinkers relative to light drinkers. Alcohol
consumption of more than 2 drinks/day significantly increased
systolic and diastolic blood pressure in normal weight and
overweight individuals, in all smoking subgroups. The strongest
association was within the group of heavy smokers, with increased
blood pressures relative to non-drinkers by 6.1/3.1 mmHg (SBP/
DBP) in normal weight individuals (P,0.001) and by 4.3/
2.2 mmHg (P=0.004) in overweight. The relationship between
alcohol consumption and blood pressure was not significant in
obese individuals.
Within normal weight individuals, higher amounts of alcohol
consumption were associated with a larger waist circumference
(Figure S1e). Among overweight individuals, alcohol consumption
up to 2 drinks/day was associated with a slightly smaller waist
circumference in non-smokers and former smokers compared to
the non-drinkers within the same smoking class (all P#0.001). A
stronger association was found for obese individuals, showing a
smaller waist up to 2.83 cm in non-smokers and up to 2.37 cm in
former smokers (all P,0.001). Obese heavy smokers with an
alcohol consumption of 1 to 2 drinks/day even had a 4.13 cm
lower waist (P=0.004).
Table 3 summarizes the relationship of light, moderate or heavy
alcohol consumption (relative to no alcohol consumption) and
smoking on the individual MetS risk components. The analyses on
the beverage-specific associations with MetS and its components
(figure 3), showed that the odds ratio of having MetS was lower for
Combined Effects of Smoking and Alcohol on Metabolic Syndrome
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wine drinkers than for non-drinkers (adjusted OR: 0.72; 95% CI:
0.68–0.84; P,0.001). Drinkers of all types of alcoholic beverages
had a lower odds ratio of meeting the HDL-C criteria (all P,
0.001) and a higher odds ratio of meeting those for hypertension
(all P,0.001). Wine drinking did not affect the odds ratio for
increased triglycerides, enlarged waist circumference or high
fasting blood glucose (P.0.004).
Discussion
In this large population-based cohort study of the metabolic
syndrome (MetS) among normal weight, overweight and obese
subjects, we found smoking and light alcohol consumption to have
opposing associations with MetS. In all BMI classes light alcohol
consumption was associated with lower prevalence of MetS,
explained by its favorable effects on HDL-C, triglycerides and
waist circumference (only in overweight and obese individuals).
Heavy alcohol consumption had unfavorable associations with
individual MetS components. When compared with non-con-
sumption of alcohol, we found wine consumption to be associated
with a lower prevalence of MetS and the separate MetS
components.
Alcohol Consumption, Smoking and MetS
As might be expected, we found a wide range of MetS
prevalence across the different smoking and alcohol subgroups and
across the different BMI classes. Normal weight and overweight
subjects with a light to moderate alcohol consumption had a lower
prevalence of MetS, while for obese subjects this was the case for
zero and light alcohol consumption. Compared to non-smokers,
former, moderate and heavy smokers had a higher prevalence of
MetS, regardless of the amount of alcohol consumed.
While our study shows a possibly protective association for
alcohol in some cases, the literature reports conflicting results on
Table 1. Characteristics of the total study population by BMI class.
Characteristics BMI,25 kg/m2 BMI 25–30 kg/m2 BMI$30 kg/m2 P value
n (%) 29,602 (46.2) 25,436 (39.7) 9,008 (14.1)
Age, yrs 42612 47612 47612 #0.001
Sex (m (%)/f) 11,269 (38.1)/18,333 13,734 (54.0)/11,702 3,721 (41.3)/5,287
BMI, kg/m2 22.661.7 27.161.4 33.463.4 #0.001
SBP, mmHg 121614 129615 133615 #0.001
DBP, mmHg 7168 7669 7769 #0.001
Total cholesterol, mmol/L 4.961.0 5.261.0 5.261.0 #0.001
LDL-C, mmol/L 3.0260.86 3.3960.90 3.3860.90 #0.001
HDL-C, mmol/L 1.5960.40 1.4060.36 1.2860.33 #0.001
Triglycerides, mmol/L 0.86 (0.63–1.11) 1.13 (0.79–1.55) 1.33 (0.93–1.83) #0.001
Blood glucose, mmol/L 4.78 (4.50–5.00) 5.04 (4.70–5.30) 5.31 (4.90–5.60) #0.001
Waist circumference, cm 8268 9468 107610 #0.001
Smoking status
Non-smoker, n (%) 14,739 (49.8) 10,951 (43.1) 3,928 (43.6) #0.001
Former smoker, n (%) 8,282 (28.0) 9,179 (36.1) 3,332 (37.0) #0.001
,20 gram tobacco/day, n (%) 5,448 (18.4) 4,157 (16.3) 1,263 (14.0) #0.001
$20 gram tobacco/day, n (%) 1,133 (3.8) 1,149 (4.5) 485 (5.4) #0.001
Alcohol intake
Non drinker 4368 (14.8) 3,811 (15.0) 2,320 (25.8) #0.001
#1 drink/day 15,933 (53.8) 12,420 (48.8) 4,220 (46.8) #0.001
.1 to 2 drinks/day 6,654 (22.5) 6,164 (24.2) 1,560 (17.3) #0.001
.2 drinks/day 2,647 (8.9) 3,041 (12.0) 908 (10.1) #0.001
Medication use
No medication, n (%) 20,200 (68.2) 16,395 (64.5) 4,835 (53.7) #0.001
#5 types of medication, n (%) 9,149 (30.9) 8,507 (33.4) 3,742 (41.5) #0.001
.5 types of medication, n (%) 253 (0.9) 534 (2.1) 431 (4.8) #0.001
BP-lowering medication, n (%) 1,145 (3.9) 2,450 (9.6) 1592 (17.7) #0.001
Statin use, n (%) 494 (1.7) 1,300 (5.1) 683 (7.6) #0.001
TG-lowering medication, n (%) 6 (0.1) 31 (0.1) 17 (0.2) #0.001
Type 2 diabetes, n (%) 99 (0.3) 302 (1.2) 339 (3.8) #0.001
Oral anti-hyperglycaemic medication, n (%) 67 (0.2) 233 (0.9) 274 (3.0) #0.001
% fulfilling$3 out of 5 MetS criteria 792 (2.7) 4,492 (17.7) 4,388 (48.7) #0.001
Data are presented as mean 6 SD, or geometric mean (interquartile range). Abbreviations: BMI = body mass index, SBP = systolic blood pressure, DBP =diastolic blood
pressure, HDL-C =high density lipoprotein cholesterol, TG = triglycerides, BP =blood pressure, MetS =metabolic syndrome.
doi:10.1371/journal.pone.0096406.t001
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the relationship between alcohol consumption and the prevalence
of MetS. Finding no association [15,16] or associations in different
directions [11–14,17,18]. The small sample size of some of these
studies and the fact that they did not take into account the smoking
status of the participants, might explain the discrepancy in these
results. However, we reported the prevalence of MetS in a large
study population and stratified by smoking and alcohol subgroups,
which gives a more reliable estimation.
Effects of Smoking and Alcohol on Metabolic Risk Factors
We have previously reported the finding that former and
current smokers have lower HDL-C levels and that this
relationship is dose-dependent [9]. We now found that this
negative influence of smoking on HDL-C may be suppressed by
the favorable association between alcohol consumption and HDL-
C. Here, we showed a dose-dependent association between alcohol
consumption and higher levels of HDL-C, which is consistent with
earlier studies [34–36]. The magnitude of the effects of alcohol
consumption on HDL-C varied between 0.02 and 0.29 mmol/L.
This means that in current smokers, moderate alcohol consump-
tion is associated with similar mean HDL-C levels to those of their
non-smoking and non-drinking counterparts within the same BMI
class.
With regard to triglyceride levels, a cross-sectional population
study has reported a U-shaped association between alcohol and
triglycerides, with triglyceride levels the lowest in people with an
alcohol consumption of 4 to 30 g/day [24]. Although our results
revealed only a few significant associations for alcohol consump-
tion, we did show higher triglyceride levels among former and
current smokers, especially among those who drink more than 2
alcoholic drinks per day. One cross-sectional study in 3311
subjects from a Chinese population concluded that the effect of
alcohol consumption on triglycerides was substantially greater for
smokers of .20 cigarettes, than for lighter smokers and non-
smokers [37]. In our population this was only true for the normal
weight individuals. For overweight and obese individuals we
cannot confirm these earlier findings (Figure S1a).
A dose-dependent relationship between alcohol consumption
and risk of hypertension has recently been suggested in a large
meta-analysis [22]. In the current study, alcohol consumption
showed a ‘J-shaped’ relationship with systolic and diastolic blood
pressure, within each BMI class.
Alcohol intake has been found to be highly correlated with both
abdominal obesity [26] and increased risk for obesity [38,39].
However, a prospective cohort study conducted among US men
over a period of nine years, found no significant associations
between changes in total alcohol consumption and gain in waist
circumference [40]. In our study, we found that normal weight
individuals who consumed alcohol had a larger waist circumfer-
ence. In contrast, among overweight and obese individuals, light
and moderate drinking was associated with a smaller waist than
non-drinking. The biological mechanism by which alcohol
consumption may reduce the waist circumference of overweight
and obese individuals remains unclear. More studies are needed to
confirm the differences that we observed between the three BMI
classes.
Table 2. Distribution of the study population across the smoking and alcohol subgroups, according to BMI class.
Non-smoker Former smoker Moderate smoker Heavy smoker
BMI ,25 kg/m2 (n=14,739) (n =8,282) (n =5,448) (n =1,133)
All, n (%) All, n (%) All, n (%) All, n (%)
Non-drinker 2791 (18.9) 864 (10.4) 554 (10.2) 159 (14.0)
#1 drink/day 8823 (59.9) 4364 (52.7) 2373 (43.6) 373 (32.9)
.1 to 2 drinks/day 2426 (16.5) 2299 (27.8) 1636 (30.0) 293 (25.9)
.2 drinks/day 699 (4.7) 755 (9.1) 885 (16.2) 308 (27.2)
Non-smoker Former smoker Moderate smoker Heavy smoker
BMI 25–30 kg/m2 (n=10,952) (n =9,179) (n =5,157) (n =1,149)
All, n (%) All, n (%) All, n (%) All, n (%)
Non-drinker 2190 (20.0) 1026 (11.2) 458 (11.0) 137 (11.9)
#1 drink/day 5980 (54.6) 4320 (47.1) 1737 (41.8) 383 (33.3)
.1 to 2 drinks/day 2025 (18.5) 2644 (28.8) 1218 (29.3) 277 (24.1)
.2 drinks/day 756 (6.9) 1189 (13.0) 744 (17.9) 352 (30.6)
Non-smoker Former smoker Moderate smoker Heavy smoker
BMI$30 kg/m2 (n=3,928) (n =3,332) (n =1,263) (n =485)
All, n (%) All, n (%) All, n (%) All, n (%)
Non-drinker 1319 (33.6) 658 (19.7) 235 (18.6) 108 (22.3)
#1 drink/day 1907 (48.5) 1607 (48.2) 539 (42.7) 167 (34.4)
.1 to 2 drinks/day 475 (12.1) 694 (20.8) 294 (23.3) 97 (20.0)
.2 drinks/day 227 (5.8) 373 (11.2) 195 (15.4) 113 (23.3)
doi:10.1371/journal.pone.0096406.t002
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Figure 1. Prevalence of metabolic syndrome within the smoking and alcohol subgroups, according to BMI class. Top: BMI,25 kg/m2;
middle: BMI 25–30 kg/m2; bottom: BMI$30 kg/m2. BMI =body mass index N: non-smokers; F: former smokers; C1: smokers of ,20 g tobacco/day;
C2: smokers of $20 g tobacco/day.
doi:10.1371/journal.pone.0096406.g001
Figure 2. Results of the associations between the smoking-alcohol subgroups and HDL-C, according to BMI class. Adjusted for age
(centered at the mean age of the total population (45y)), sex and the number of medications used. * indicates a significant difference within each
smoking subgroup relative to the reference group of non-drinkers (shaded shape); P value#0.001. N: non-smokers; F: former smokers; C1: smokers of
,20 g tobacco/day; C2: smokers of$20 g tobacco/day. 0: non-drinker; 1:#1 drink/day; 2:.1–2 drinks/day; 3:.2 drinks/day. BMI = body mass index
HDL-C= high-density lipoprotein cholesterol.
doi:10.1371/journal.pone.0096406.g002
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We showed with our study that all metabolic parameters worsen
with higher BMI. Reducing body weight would therefore be by far
the best approach to reduce the prevalence of MetS. However,
effective long-term successes of weight loss interventions are still
missing [4,5]. Recently, a paper has been published on the effects
of metabolic mediators on coronary heart disease (CHD) and
stroke within overweight and obesity [41]. They have estimated
that nearly half of the excess risk for CHD and three-quarters of
excess risk for stroke due to overweight and obesity were mediated
through blood pressure, cholesterol and glucose. Blood pressure
accounted for the highest percentage of excess risk for CHD (one-
third) and stroke (two-third). Interventions that control metabolic
factors might address a substantial proportion of the effect of high
BMI on cardiovascular disease. However, to achieve full benefits
from the interventions, reduction of body weight is recommended.
The Effect of Beverage Type on MetS and its
Components
The odds ratios of having MetS were lower for consumers of all
types of alcoholic beverage than for non-drinkers, a finding also
reported by Djousse´ et al. [42]. However, in the present study, wine
Table 3. Overview of the relationships of light, moderate or heavy alcohol consumption (relative to non-consumption) and
smoking on the individual MetS risk components.
Risk component Light alcohol use Moderate alcohol use Heavy alcohol use Smoking
HDL-cholesterol qq qq qq QQ
Triglycerides Q q q q
Blood glucose N N q N
Blood pressure Q N qq N
Waist circumference ?a ?a ?a q
Larger arrows and two arrows indicate a stronger association. N = neutral association.
aassociation depends on the body mass index: a larger waist circumference for BMI ,25 kg/m2 and a smaller waist circumference for BMI$25 kg/m2.
doi:10.1371/journal.pone.0096406.t003
Figure 3. Odds ratios for MetS and the individual components according to type of alcoholic beverage. This analysis comprised 10,499
non-drinkers (reference group), 18,581 wine consumers, 20,894 beer consumers and 4,079 spirits/mixed drinks consumers, for all levels of alcohol
consumption. Adjusted for age, sex, level of alcohol consumption, body mass index class, smoking subgroup and the number of medications used.
Odds ratios were significant different from the reference group of non-drinkers at P value#0.004. a indicates a significant difference relative to the
reference group of non-drinkers at P value#0.05. BG= fasting blood glucose; BP =blood pressure; HDL-C= high-density lipoprotein cholesterol;
MetS =metabolic syndrome; TG= triglycerides; WC=waist circumference.
doi:10.1371/journal.pone.0096406.g003
Combined Effects of Smoking and Alcohol on Metabolic Syndrome
PLOS ONE | www.plosone.org 7 April 2014 | Volume 9 | Issue 4 | e96406
consumption resulted in the lowest odds ratio of having MetS and
was the only significant association (P#0.004). This suggests that
the lowest odds ratio we observed for the wine drinkers, may be
explained by other components than ethanol and/or the healthier
lifestyle behavior associated with wine consumption [42,43]. The
overall metabolic profile of wine consumers was better than that of
individuals who preferred other alcoholic beverages. Wine
drinkers were also less likely to be current smokers (data not
shown).
When we investigated the individual components of MetS we
found the odds ratio of having low HDL-C levels to be lower for
all beverage types than for non-drinkers. For beer consumption
the only association found was a slightly higher odds ratio of
having hypertriglyceridemia. The fact that the odds ratio was
higher for beer consumers can be explained by the high
carbohydrate content of beer, which is a well-known risk factor
for increased triglycerides [44]. The finding that the odds ratio of
having hypertension was lower for wine drinkers than for
consumers of the other types of beverages, is also reported by
another study [45]. Higher odds ratios for abdominal obesity were
found for drinkers of spirits/mixed drinks and beer, although not
significant for the latter (P=0.043). These findings are in line with
those reported by Valdstrup and colleagues [46].
Strengths and Limitations
A major strength of our study is the nature of the study
population, which is derived from the general population and both
large and well characterized. We are the first to report on
associations between the concurrent use of tobacco and alcohol
and the various components of MetS. The sample size of 64,046
individuals allowed us to perform subgroup analyses within
different smoking subgroups and BMI classes. We were even able
to examine whether the presence of MetS and its components was
associated with the type of alcoholic beverage consumed.
However, the study still has some limitations. Firstly, we were
unable to make a distinction between abstainers and former
drinkers. In this respect, the ‘J-shaped’ relationships found
between alcohol consumption and both blood pressure and
triglycerides might be explained by the lower health status of the
non-drinking group (more medication users and type 2 diabetes
patients) and possible inclusion of former drinkers. However, the
‘J-shaped’ relationship remained after exclusion of individuals with
medication use. Secondly, the relationship between smoking,
alcohol and MetS may be confounded by levels of physical activity
and food intake. Smokers are known to be less physical active and
have a less healthy diet than non-smokers [47]. Light and
moderate alcohol consumption, in particular wine, is usually
associated with a healthier lifestyle [47]. This notion is supported
by the fact that beer and wine (which have the same ethanol
content) showed different associations with MetS and its compo-
nents. Such differences may be explained by lifestyle-related risk
factors in consumers of beer, wine and spirits/mixed drinks that
we could not control. Although we were not able to account for
multiple critical lifestyle factors, we are the first to report in detail
the combined effect of smoking and alcohol consumption on
MetS. Thirdly, our findings could not support causality, due to the
cross-sectional design of this study. A final point, which might be
seen as a limitation, is the possibility of misclassification, since
smoking and alcohol consumption was based on self-administered
questionnaires. However, earlier studies showed that self-reported
smoking status, tobacco use and alcohol consumption in the
general population, can be used with notable confidence and
provide an accurate estimation of the actual substance use [48–
50].
Conclusion
In our previous study we already showed that smoking was
associated with a higher risk for MetS, explained by its negative
influence on HDL-C, triglycerides and to a lesser extend waist
circumference. With the current study we assessed the combined
effect of smoking and alcohol consumption on MetS. In this large
population-based cohort study we found that especially light
alcohol consumption was associated with a favorable effect on the
individual MetS components. Light alcohol consumption might
therefore moderate the negative associations of smoking on MetS.
Our results suggest that the lifestyle advice that emphasizes
smoking cessation and the restriction of alcohol consumption to a
maximum of 1 drink/day, is a good approach to reduce the
prevalence of MetS. Maintaining a healthy body weight is
recommended to fully benefit from this approach. These
lifestyle advices may also help to prevent the onset of cardiovas-
cular disease, since it is the main health risk attributable to
MetS.
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